NCT02205801 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.25% Marcaine. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
- id
- FG000
- title
- Superficial Cervical Block, Active
- description
- After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.9% saline. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
- id
- FG001
- title
- Superficial Cervical Block, Placebo
- description
- After induction of general anesthesia the surgeon will perform a local wound infiltration using 0.25% Marcaine. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
- id
- FG002
- title
- Local Wound Infiltration, Active
- description
- After induction of general anesthesia the surgeon will perform local wound infiltration using 0.9% Saline. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
- id
- FG003
- title
- Local Wound Infiltration, Placebo
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 9
- group Id
- FG003
- num Subjects
- 8
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 9
- group Id
- FG003
- num Subjects
- 8
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.25% Marcaine. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
- id
- FG000
- title
- Superficial Cervical Block, Active
- description
- After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.9% saline. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
- id
- FG001
- title
- Superficial Cervical Block, Placebo
- description
- After induction of general anesthesia the surgeon will perform a local wound infiltration using 0.25% Marcaine. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
- id
- FG002
- title
- Local Wound Infiltration, Active
- description
- After induction of general anesthesia the surgeon will perform local wound infiltration using 0.9% Saline. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
- id
- FG003
- title
- Local Wound Infiltration, Placebo
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 9
- group Id
- FG003
- num Subjects
- 8
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 11
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 9
- group Id
- FG003
- num Subjects
- 8
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle